BioCorRx (QB) Stock Price - BICX

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
BioCorRx Inc (QB) BICX OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.1068 -3.72% 2.7632 2.825 2.50 2.825 2.87 12:49:18
Bid Price Ask Price Spread Spread % News
2.76 2.80 0.04 1.43% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
10 1,769 $ 2.6484 $ 4,685 1,686 0.05 - 8.49
Last Trade Time Type Quantity Stock Price Currency
13:47:06 25 $ 2.77 USD

BioCorRx (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 14.63M 5.30M $ -6.51M - - 2.27M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
14.85k $ - 0.00% - -

more financials information »

BioCorRx (QB) News

Loading Messages....

Latest BICX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BICX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.303.402.503.141,239-0.5368-16.27%
1 Month3.743.952.503.27854-0.9768-26.12%
3 Months3.154.022.463.171,884-0.3868-12.28%
6 Months4.514.682.463.421,948-1.75-38.73%
1 Year0.07788.490.050.359821125,8462.693,451.67%
3 Years0.0288.490.02270.1448871309,4542.749,768.57%
5 Years0.107128.490.010.1296845221,7942.662,479.54%

BioCorRx (QB) Description

BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The full program is estimated to launch in October 2019. The Company is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Specifically, the company is developing an injectable (BICX101) and implantable naltrexone (BICX102) with the goal of future regulatory approval with the Food and Drug Administration. For more information on BICX, visit www.BioCorRx.com.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.